Eyenovia receives Nasdaq bid price deficiency notice; has until March 17, 2025 to regain compliance

HYPERION DEFI, INC.

Received Nasdaq deficiency letter on Sept 18, 2024; bid price below $1.00 for 30 consecutive business days.
Initial compliance period ends March 17, 2025; must close at $1.00+ for 10 consecutive business days.
If not cured, may qualify for additional 180-day period if meeting other listing standards.
Stock continues trading under symbol 'EYEN' on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.